CEFORANIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ceforanide and what is the scope of patent protection?
Ceforanide
is the generic ingredient in one branded drug marketed by Apothecon and Bristol, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for ceforanide.
Summary for CEFORANIDE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 2 |
| NDAs: | 2 |
| Drug Master File Entries: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 5,662 |
| DailyMed Link: | CEFORANIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CEFORANIDE
US Patents and Regulatory Information for CEFORANIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bristol | PRECEF | ceforanide | INJECTABLE;INJECTION | 050554-001 | May 24, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol | PRECEF | ceforanide | INJECTABLE;INJECTION | 050554-005 | May 24, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol | PRECEF | ceforanide | INJECTABLE;INJECTION | 050554-002 | May 24, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bristol | PRECEF | ceforanide | INJECTABLE;INJECTION | 050554-004 | May 24, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRECEF | ceforanide | INJECTABLE;INJECTION | 062579-003 | Nov 26, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Apothecon | PRECEF | ceforanide | INJECTABLE;INJECTION | 062579-004 | Nov 26, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
